Radiation therapy versus delayed androgen deprivation for stage C carcinoma of the prostate

Autor:	Bernard Hickman, Kent Woodard, W. Kenneth Poole, Vincent Ciavarra, Keene M. Wallace, Roy P. Finney, Bernard Roswit, Carl A. Olsson, Ulysses S. Seal, Alptekin Ucmakli, D.R. Harris, Samuel S. Clark, Nelson A. Moffat, Robert Greenlaw, Nabil Bissada, James Nickson, John R. Canning, Richard B. Bourne, Ralph Jensen, Wanda Hinshaw, Edwin J. Liebner, R. Byhardt, G. Byron Hodge, William Lamar Weems, Willis P. Jordan, Stefano S. Stefani, William R. Turner, David F. Paulson
Rok vydání:	1984
Předmět:	Oncology Male medicine.medical_specialty Disease Response medicine.drug_class Urology medicine.medical_treatment Adenocarcinoma Pelvis Radiotherapy High-Energy Prostate Internal medicine medicine Carcinoma Humans Castration Stage (cooking) Diethylstilbestrol Aged business.industry Prostatic Neoplasms Middle Aged Androgen medicine.disease Radiation therapy medicine.anatomical_structure Lymphatic Metastasis Androgens Hormonal therapy business
Zdroj:	The Journal of urology. 131(5)
ISSN:	0022-5347
Popis:	Seventy-three patients with prostatic adenocarcinoma who were believed to have disease limited to the pelvis without evidence of node or bone extension were assigned randomly to either full-field pelvic radiation (40) or delayed hormonal therapy (33). The interval to first evidence of treatment failure was used as the end point of the study. Failures occurred in 13 patients who received radiation therapy and 11 who received delayed hormonal therapy. No difference in disease response could be identified between the 2 treatment groups.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2b8eeb2873885f707e946772c914a7a https://pubmed.ncbi.nlm.nih.gov/6423840 Zobrazit plný text záznamu